AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 36 filers reported holding AQUINOX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $127,000 | -14.8% | 53,687 | -3.3% | 0.00% | – |
| Q1 2019 | $149,000 | +24.2% | 55,543 | 0.0% | 0.00% | – |
| Q4 2018 | $120,000 | -53.7% | 55,543 | -37.2% | 0.00% | – |
| Q3 2018 | $259,000 | +10.2% | 88,437 | -0.1% | 0.00% | – |
| Q2 2018 | $235,000 | -81.2% | 88,493 | -0.3% | 0.00% | – |
| Q1 2018 | $1,250,000 | +25.3% | 88,770 | +4.7% | 0.00% | – |
| Q4 2017 | $998,000 | -17.5% | 84,817 | -0.5% | 0.00% | – |
| Q3 2017 | $1,209,000 | +3.2% | 85,239 | +2.4% | 0.00% | – |
| Q2 2017 | $1,171,000 | -12.9% | 83,207 | +3.3% | 0.00% | – |
| Q1 2017 | $1,344,000 | -0.9% | 80,516 | -2.0% | 0.00% | – |
| Q4 2016 | $1,356,000 | +58.4% | 82,121 | +28.2% | 0.00% | – |
| Q3 2016 | $856,000 | +154.8% | 64,033 | +26.2% | 0.00% | – |
| Q2 2016 | $336,000 | +184.7% | 50,732 | +277.6% | 0.00% | – |
| Q1 2016 | $118,000 | -29.8% | 13,434 | 0.0% | 0.00% | – |
| Q4 2015 | $168,000 | -11.1% | 13,434 | 0.0% | 0.00% | – |
| Q3 2015 | $189,000 | – | 13,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,396,071 | $19,643,000 | 2.25% |
| Boxer Capital, LLC | 525,000 | $7,387,000 | 1.76% |
| Baker Brothers Advisors | 10,934,154 | $153,844,000 | 1.34% |
| EMORY UNIVERSITY | 105,815 | $1,489,000 | 1.32% |
| Ghost Tree Capital, LLC | 300,000 | $4,221,000 | 0.88% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,217 | $2,409,000 | 0.71% |
| NEXTHERA CAPITAL LP | 90,700 | $1,276,000 | 0.56% |
| Eventide Asset Management | 175,000 | $2,462,000 | 0.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 62,085 | $874,000 | 0.15% |
| ASCEND CAPITAL, LLC | 214,328 | $3,017,000 | 0.14% |